Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease. (Q48447447)

11 February 2018

title

Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease. (English)

1 reference

11 February 2018

0 references

1 reference

Moeko Noguchi-Shinohara

1

1 reference

11 February 2018

Junji Komatsu

2

1 reference

11 February 2018

Miharu Samuraki

3

1 reference

11 February 2018

Ichiro Matsunari

4

1 reference

11 February 2018

Tokuhei Ikeda

5

1 reference

11 February 2018

Kenji Sakai

6

1 reference

11 February 2018

Tsuyoshi Hamaguchi

7

1 reference

11 February 2018

Kenjiro Ono

8

1 reference

11 February 2018

Hiroyuki Nakamura

9

1 reference

11 February 2018

Masahito Yamada

10

1 reference

11 February 2018

publication date

11 October 2016

1 reference

11 February 2018

Journal of Alzheimer's Disease

published in

1 reference

11 February 2018

volume

55

1 reference

11 February 2018

page(s)

905-913

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Cerebral amyloid angiopathy: emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Differences between vascular and plaque core amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Microbleeds do not affect rate of cognitive decline in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Microbleeds, Mortality, and Stroke in Alzheimer Disease: The MISTRAL Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Cerebral microbleeds in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Prevalence and severity of microbleeds in a memory clinic setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Microbleed Topography, Leukoaraiosis, and Cognition in Probable Alzheimer Disease From the Sunnybrook Dementia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160651

21 January 2018

Identifiers

0 references

1 reference

11 February 2018